Posts Tagged ‘macrophages’


Proneuron Biotechnologies Teams with Craig Hospital

Posted on December 18th, 2003

Proneuron Biotechnologies Teams with Craig Hospital in Denver to Expand IND Phase II Trial of ProCord for the Treatment of Spinal Cord Injuries to the U.S.

Proneuron Biotechnologies, Inc. (www.proneuron.com), and Craig Hospital (www.craighospital.org) announced today that enrollment in Proneuron’s IND Phase II trial of ProCord is now open to patients at Craig Hospital in Denver, Colorado. Proneuron is a leader in the development of treatments for patients with spinal cord injuries and other acute and chronic disorders of the central nervous system (CNS). Proneuron’s processing Cell Center at Craig is the first U.S. site that will test ProCord, which consists of autologous activated macrophage therapy for a randomized controlled trial for patients with acute complete spinal cord injury (SCI) within 14 days of injury.

Read more of Proneuron Biotechnologies Teams with Craig Hospital »